Metabolium appoints Khadidja Romari as chief executive

9 April 2015

French biotech company Metabolium has appointed Khadidja Romari as chief operating officer and chief scientific director.

Before this appointment, Dr Romari spent several months as scientific advisor to Dominique Duvauchelle, the chief executive of Metabolium, to gain an understanding of the technologies developed by the company.

She brings more than 20 years of experience in product development in aquaculture, dietary supplements, cosmetic and pharma industries, and before joining the company she helped to develop American companies such as Bigelow Laboratory for Ocean Sciences.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK